Sanofi and Cheplapharm Announce Strategic Partnership for 20 Mature Medicines and Three Sites
Sanofi and Cheplapharm plan to transfer 20 mature medicines and three manufacturing sites to Cheplapharm, with Sanofi set to receive a 26.4 percent equity stake.
Company Collaboration | 16/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy